Author: Ken Dropiewski

MedHub Receives CE Mark Approval for its AutoCathFFR Software

TEL AVIV, Israel, Sept. 22, 2020 /PRNewswire/ — MedHub, a med-tech company that is leveraging AI to help interventional cardiologists make better decisions, announced today that its AutoCathFFR system has been certified to bear the CE Mark, signifying compliance with the European Union’s health and environmental safety regulations. “Following our recent AMAR regulatory approval, the […]

Laurel Bridge Software and Ultromics Partnership Increases Accessibility to AI Solutions for Echocardiography

NEWARK, Del., Sept. 22, 2020 /PRNewswire/ — Laurel Bridge Software, a provider of software solutions that enable healthcare organizations to orchestrate their medical imaging workflows, announces a new partnership with Ultromics, a global health technology firm, which provides autonomous echocardiography analysis through innovative AI solutions. The Laurel Bridge AI Workflow Suite (AIWS) enables the Ultromics EchoGo suite of cloud-based AI […]

MicroVention-Terumo Announces New Leadership

The Company Appoints New President and CEO ALISO VIEJO, Calif., Sept. 22, 2020 /PRNewswire/ — MicroVention, Inc., a U.S. based subsidiary of Terumo and leading global neurovascular company, announced today the appointment of a new President and CEO, Mr. Carsten Schroeder. The MicroVention acting President and CEO, Kazuaki Kitabatake, who has been in his […]

Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments

MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the appointment of Lisa Giles and Robert Wills to its Board of Directors, effective October 1, 2020. Ms. Giles will serve as a member of the Audit Committee of the Board and Dr. […]

PEDRA™ Technology, Inc. Secures $4.7M Series A Funding for Perfusion Monitoring Technology

Novel perfusion monitoring system injects new precision into the treatment of peripheral artery disease and critical limb ischemia SINGAPORE, Sept. 22, 2020 /PRNewswire/ — PEDRA™ Technology, a Singapore-based developer of innovative deep-tissue perfusion monitors, today announced the completion of $4.7M Series A financing, with investors including SEEDS Capital, the investment arm of Enterprise Singapore,  M&L Healthcare Investments and […]

VivaLNK Supports Large Scale Atrial Fibrillation Study of Wearable ECG Sensors

Multi-year, 3,000 subjects study aims to detect biomarkers of early atrial transformation in atrial fibrillation CAMPBELL, Calif., Sept. 22, 2020 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare devices, announces that the University of California, San Francisco (UCSF) will be utilizing its continuous wearable ECG sensor for a 3,000 subject multi-year study on atrial […]

JanOne Issues September 2020 Shareholder Letter Updating Investors on Recent Pharma Asset Potential for Peripheral Artery Disease

Company pursuing additional application for JAN101 to treat COVID-19 complications Stable formulation and engineering for JAN101 will support Phase 2b PAD Study under the FDA’s Investigational New Drug (IND) #111703, expected to begin the first quarter of 2021 Scientific Advisory Board bolstered by expert additions LAS VEGAS, Sept. 22, 2020 /PRNewswire/ — JanOne […]

CB Scientific, Inc. (CBSC) Announces Completion of Asset Purchase Agreement and Commencement of Its ECG Monitoring Business

An experienced executive management team is leading the way in the FDA and CE-cleared cardiac monitoring products and services arena, using smart phones and cloud-based software technology ESCONDIDO, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) — via NetworkWire — CB Scientific, Inc. (OTC: CBSC) (“CBSC” or the “Company”), a provider of […]

RapidAI Announces $25 Million in Series B Funding to Expand AI-Enhanced Cerebrovascular Imaging Worldwide

SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the worldwide leader in advanced imaging for stroke, today announced a $25 million Series B round of funding by Lennertz & Co. Building on years of profitability, these additional funds will accelerate the company’s strategic growth initiatives around the world. Founded in 2011, RapidAI makes the […]